Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Factor Xa inhibitors have a favorable benefit–risk profile for the treatment and prevention of thrombotic events but may cause or worsen acute major bleeding, with substantial morbidity and mortality. Acute major bleeding episodes that are associated with the use of factor Xa inhibitors may be…

http://bit.ly/2RV6pvm